Active Ingredient: IBANDRONATE SODIUM
Proprietary Name: IBANDRONATE SODIUM
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: EQ 3MG BASE/3ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A204329
Product Number: 001
Approval Date: Jun 16, 2021
Applicant Holder Full Name: NANG KUANG PHARMACEUTICAL CO LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information